Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183174145> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2183174145 endingPage "25" @default.
- W2183174145 startingPage "25" @default.
- W2183174145 abstract "Purpose: The biological activity (direct anticancer action in vitro) of combinatorial IL-2 succinylated derivatives was examined. Acylation of IL-2 was performed using succinic anhydride with various levels of acylation, with the formation of a complex assembly of many derivatives (self-assembled quasi-living structure).Methods: In the study, we used recombinant interleukin-2 (IL-2) (Ronkoleukin, Russia) in oxidizing form and other reagents from Sigma-Aldrich and Fluka (USA). For acylation, recombinant IL-2 in the form of a matrix fluid with a protein concentration of 0.6 mg/ml was used. The IL-2 matrix solution was brought to a pH of 8.0 through the addition of a 0.01% solution of sodium hydroxide. The synthesized ensemble of succinyl-IL-2 was analyzed using the capillary gel electrophoresis method in an Agilent-2100 bioanalyzer. The molecular masses of the synthesized ensemble were established in comparison to standard samples of low-molecular proteins with known molecular masses that were part of the bioanalyzer’s collection. The additional negative charge of the modified IL-2 was determined by a FPLC (Fast Protein Liquid Chromatography) system from Pharmacia (Woerden, Netherlands). CTLL-2, a murine IL-2-dependent cell line, was obtained fromBiokontrol (Kiev, Ukraine). These respondingcells were used in proliferative assays comparing the activityof the IL-2 and succinylated IL-2 derivatives to the WHO InternationalStandard. For statistical data analysis, the one-way ANOVA was used.Results: After treatment with Suc-IL-2, BTL were studied in vitro on the CTLL-2 cell line, dose-dependently, in a BTL induction reaction. The highest level of biological activity in acylated IL-2 was observed in Suc-IL-2 with four modified lysine residues. In conclusion, succinylated IL-2 with four substituted lysines may be useful as a prospective anticancer agent.Conclusions: Ten-fold increase in the biological activity of IL-2 was observed after partial succinylation. This phenomenon can be used in the further IL-2 drugs biotechnological development for increasing the concentration of the main active substance in medicinal form" @default.
- W2183174145 created "2016-06-24" @default.
- W2183174145 creator A5016746802 @default.
- W2183174145 creator A5045595282 @default.
- W2183174145 creator A5051764277 @default.
- W2183174145 creator A5055466540 @default.
- W2183174145 date "2015-11-29" @default.
- W2183174145 modified "2023-09-27" @default.
- W2183174145 title "Synthesis of the ensembles from succinylated interleukin-2 derivatives and their biological activity in vitro" @default.
- W2183174145 cites W1550885672 @default.
- W2183174145 cites W1977096306 @default.
- W2183174145 cites W1995879902 @default.
- W2183174145 cites W2005938837 @default.
- W2183174145 cites W2021765574 @default.
- W2183174145 cites W2037557484 @default.
- W2183174145 cites W2076756139 @default.
- W2183174145 cites W2096454260 @default.
- W2183174145 cites W2108117103 @default.
- W2183174145 cites W2109143032 @default.
- W2183174145 cites W2443967236 @default.
- W2183174145 cites W2470716710 @default.
- W2183174145 cites W91395500 @default.
- W2183174145 doi "https://doi.org/10.15587/2313-8416.2015.53985" @default.
- W2183174145 hasPublicationYear "2015" @default.
- W2183174145 type Work @default.
- W2183174145 sameAs 2183174145 @default.
- W2183174145 citedByCount "1" @default.
- W2183174145 countsByYear W21831741452018 @default.
- W2183174145 crossrefType "journal-article" @default.
- W2183174145 hasAuthorship W2183174145A5016746802 @default.
- W2183174145 hasAuthorship W2183174145A5045595282 @default.
- W2183174145 hasAuthorship W2183174145A5051764277 @default.
- W2183174145 hasAuthorship W2183174145A5055466540 @default.
- W2183174145 hasBestOaLocation W21831741451 @default.
- W2183174145 hasConcept C104317684 @default.
- W2183174145 hasConcept C161790260 @default.
- W2183174145 hasConcept C178790620 @default.
- W2183174145 hasConcept C179998833 @default.
- W2183174145 hasConcept C185592680 @default.
- W2183174145 hasConcept C193557335 @default.
- W2183174145 hasConcept C195310446 @default.
- W2183174145 hasConcept C202751555 @default.
- W2183174145 hasConcept C2777735259 @default.
- W2183174145 hasConcept C2900643 @default.
- W2183174145 hasConcept C40767141 @default.
- W2183174145 hasConcept C40875361 @default.
- W2183174145 hasConcept C43617362 @default.
- W2183174145 hasConcept C55493867 @default.
- W2183174145 hasConceptScore W2183174145C104317684 @default.
- W2183174145 hasConceptScore W2183174145C161790260 @default.
- W2183174145 hasConceptScore W2183174145C178790620 @default.
- W2183174145 hasConceptScore W2183174145C179998833 @default.
- W2183174145 hasConceptScore W2183174145C185592680 @default.
- W2183174145 hasConceptScore W2183174145C193557335 @default.
- W2183174145 hasConceptScore W2183174145C195310446 @default.
- W2183174145 hasConceptScore W2183174145C202751555 @default.
- W2183174145 hasConceptScore W2183174145C2777735259 @default.
- W2183174145 hasConceptScore W2183174145C2900643 @default.
- W2183174145 hasConceptScore W2183174145C40767141 @default.
- W2183174145 hasConceptScore W2183174145C40875361 @default.
- W2183174145 hasConceptScore W2183174145C43617362 @default.
- W2183174145 hasConceptScore W2183174145C55493867 @default.
- W2183174145 hasIssue "4 (16)" @default.
- W2183174145 hasLocation W21831741451 @default.
- W2183174145 hasOpenAccess W2183174145 @default.
- W2183174145 hasPrimaryLocation W21831741451 @default.
- W2183174145 hasRelatedWork W2008937680 @default.
- W2183174145 hasRelatedWork W2013157334 @default.
- W2183174145 hasRelatedWork W2089074688 @default.
- W2183174145 hasRelatedWork W2091973281 @default.
- W2183174145 hasRelatedWork W2183174145 @default.
- W2183174145 hasRelatedWork W2325398946 @default.
- W2183174145 hasRelatedWork W2778510088 @default.
- W2183174145 hasRelatedWork W2952252258 @default.
- W2183174145 hasRelatedWork W2952256733 @default.
- W2183174145 hasRelatedWork W2953155228 @default.
- W2183174145 hasVolume "11" @default.
- W2183174145 isParatext "false" @default.
- W2183174145 isRetracted "false" @default.
- W2183174145 magId "2183174145" @default.
- W2183174145 workType "article" @default.